Streetbeat News

Regulatory

PEPG

PepGen has withdrawn its prior guidance for initiating a Phase 1 study of PGN-EDODM1 in patients with myotonic dystrophy type 1 (DM1) in the first half of 2023, as it awaits an official clinical hold letter from the FDA.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:09 pm

VTRS

Viatris (VTRS) received notice that an applicant has submitted an Abbreviated New Drug Application (ANDA) to the FDA, seeking approval for a generic version of Tyrvaya.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:06 pm

HGEN

Humanigen has been granted a US patent for a method of increasing the efficacy of CAR-T immunotherapy using Lenzilumab. The patent covers the use of Lenzilumab in combination with CAR-T therapy to enhance its effectiveness.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:05 pm

THRN

Horne Healthtech Inc received a notice from Nasdaq on June 6, indicating that it is no longer in compliance with Listing Rule 5605(C)(2)(A).

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 8:04 pm

UPST

Upstart Holdings Inc (UPST) shares are trading higher by 9.30% to $36.85 on Tuesday, possibly due to the softer-than-expected CPI report showing slowing inflation in May. Lower inflation rates can improve consumer purchasing power and affordability, leading to increased loan applications and utilization of lending platforms like Upstart.

Portfolio Pulse from Henry Khederian

June 13, 2023 | 7:23 pm

CAT

DE

Industrial stocks are trading higher due to overall market strength following May CPI data and China's central bank cutting the seven-day reverse repurchase rate, potentially lifting economic growth outlook.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 7:14 pm

BP

CVE

A preliminary report by the U.S. Chemical Safety and Hazard Investigation Board suggests that supervisors at the Ohio BP-Husky refinery ignored warning signs and continued to run the plant despite malfunctions and a petroleum spill, leading to a fatal accident that killed two workers last year. Cenovus Energy Inc (NYSE:CVE) acquired the remaining 50% of the Toledo Refinery for $300 million from BP plc (NYSE:BP) in February 2023.

Portfolio Pulse from Vandana Singh

June 13, 2023 | 6:51 pm

ABT

SRDX

Surmodics Inc has resubmitted its SurVeil drug-coated balloon premarket approval application with no new testing required. Needham upgraded the stock from Hold to Buy with a price target of $36, expecting SurVeil to be approved by the FDA sooner than previously thought.

Portfolio Pulse from Vandana Singh

June 13, 2023 | 6:40 pm

LCID

Lucid Group Inc (NASDAQ:LCID) shares are trading higher by 4.15% to $6.53 as stocks rise following a softer-than-expected CPI report, which showed slowing inflation in May. Lower interest rates can stimulate borrowing and make auto loans more affordable, potentially driving up car sales.

Portfolio Pulse from Henry Khederian

June 13, 2023 | 6:36 pm

SPY

The White House has stated that there is a cooling in the housing market, indicating a potential slowdown in the sector.

Portfolio Pulse from Benzinga Newsdesk

June 13, 2023 | 6:20 pm